NO20053018L - Pyrazoloquinoliner med immunmodulerende aktivitet. - Google Patents
Pyrazoloquinoliner med immunmodulerende aktivitet.Info
- Publication number
- NO20053018L NO20053018L NO20053018A NO20053018A NO20053018L NO 20053018 L NO20053018 L NO 20053018L NO 20053018 A NO20053018 A NO 20053018A NO 20053018 A NO20053018 A NO 20053018A NO 20053018 L NO20053018 L NO 20053018L
- Authority
- NO
- Norway
- Prior art keywords
- pyrazoloquinolines
- methods
- immunomodulatory activity
- heterocyclic compounds
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42824002P | 2002-11-22 | 2002-11-22 | |
| SE0203471A SE0203471D0 (sv) | 2002-11-22 | 2002-11-22 | Immunomodulatory compunds |
| SE0301299A SE0301299D0 (sv) | 2003-05-06 | 2003-05-06 | Immunomodulatory compounds |
| US48212203P | 2003-06-25 | 2003-06-25 | |
| SE0301851A SE0301851D0 (sv) | 2003-06-25 | 2003-06-25 | Immunomodulatory compounds |
| PCT/SE2003/001805 WO2004048378A1 (en) | 2002-11-22 | 2003-11-21 | Pyrazoloquinolines with immunomodulating activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20053018D0 NO20053018D0 (no) | 2005-06-20 |
| NO20053018L true NO20053018L (no) | 2005-08-22 |
Family
ID=32398347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20053018A NO20053018L (no) | 2002-11-22 | 2005-06-20 | Pyrazoloquinoliner med immunmodulerende aktivitet. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7081456B2 (ru) |
| EP (2) | EP1562944B1 (ru) |
| JP (1) | JP2006509047A (ru) |
| CN (1) | CN100347173C (ru) |
| AT (1) | ATE353898T1 (ru) |
| AU (1) | AU2003279687A1 (ru) |
| CA (1) | CA2506524A1 (ru) |
| DE (1) | DE60311861T2 (ru) |
| ES (1) | ES2282693T3 (ru) |
| HK (1) | HK1086562A1 (ru) |
| NO (1) | NO20053018L (ru) |
| NZ (1) | NZ540081A (ru) |
| RU (1) | RU2328496C2 (ru) |
| WO (1) | WO2004048378A1 (ru) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1572689B1 (en) * | 2002-12-16 | 2009-03-11 | Active Biotech AB | Tetracyclic immunomodulatory compounds |
| EP1603917B1 (en) | 2003-03-14 | 2010-11-24 | MediGene Ltd. | Immunomodulating heterocyclic compounds |
| GB0325644D0 (en) | 2003-11-04 | 2003-12-10 | Avidex Ltd | Immuno ihibitory pyrazolone compounds |
| EP1776366B1 (en) | 2004-08-09 | 2008-10-15 | MediGene Ltd. | Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors |
| WO2008043072A2 (en) * | 2006-10-05 | 2008-04-10 | Biogen Idec Inc. | Cd80 antagonists for treating neoplastic disorders |
| EP2676666A1 (en) * | 2012-06-20 | 2013-12-25 | Eidgenössische Technische Hochschule Zürich (ETH) | Compounds for use in diagnosis or therapy of vulnerable atherosclerotic plaques |
| CN102977095B (zh) * | 2012-12-03 | 2015-10-28 | 华东理工大学 | 吡唑并喹啉类化合物及其用途 |
| US9809589B2 (en) * | 2012-12-22 | 2017-11-07 | Kbp Biosciences Co., Ltd. | Crystal form of compound used as mineralocorticoid receptor antagonist and preparation method therefor |
| EP2883883A1 (en) | 2013-12-16 | 2015-06-17 | Cardio3 Biosciences S.A. | Therapeutic targets and agents useful in treating ischemia reperfusion injury |
| CN110698456B (zh) * | 2019-11-06 | 2021-05-14 | 重庆医药高等专科学校 | 一种2,3-二氢硫代色烯-4-酮及其衍生物的合成方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4268516A (en) * | 1978-10-11 | 1981-05-19 | Pfizer Inc. | [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents |
| US4312870A (en) * | 1979-06-21 | 1982-01-26 | Ciba-Geigy Corporation | Pyrazoloquinolines |
| PH21213A (en) * | 1984-10-26 | 1987-08-21 | Fujisawa Pharmaceutical Co | Benzene- and pyrazole- fused heterocyclic compound and pharmaceutical composition comprising the same |
| US4758427A (en) * | 1985-08-08 | 1988-07-19 | Ciba-Geigy Corporation | Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone |
| CA2074841A1 (en) * | 1990-02-02 | 1991-08-03 | Roger B. Titman | Therapeutic agents |
| GB9002423D0 (en) * | 1990-02-06 | 1990-04-04 | Boots Co Plc | Therapeutic agents |
| CN1069272A (zh) * | 1991-08-02 | 1993-02-24 | 布茨公司 | 制备苯并吡或噻喃并吡唑的方法 |
| ID16283A (id) * | 1996-03-20 | 1997-09-18 | Astra Pharma Prod | Senyawa yang berguna dibidang farmasi |
| SE0102404D0 (sv) * | 2001-07-04 | 2001-07-04 | Active Biotech Ab | Novel immunomodulating compounds |
| US6642249B2 (en) * | 2001-07-04 | 2003-11-04 | Active Biotech Ab | Immunomodulating compounds |
-
2003
- 2003-11-21 ES ES03773026T patent/ES2282693T3/es not_active Expired - Lifetime
- 2003-11-21 NZ NZ540081A patent/NZ540081A/en unknown
- 2003-11-21 EP EP03773026A patent/EP1562944B1/en not_active Expired - Lifetime
- 2003-11-21 DE DE60311861T patent/DE60311861T2/de not_active Expired - Lifetime
- 2003-11-21 AT AT03773026T patent/ATE353898T1/de not_active IP Right Cessation
- 2003-11-21 RU RU2005119639/04A patent/RU2328496C2/ru not_active IP Right Cessation
- 2003-11-21 JP JP2005510306A patent/JP2006509047A/ja not_active Withdrawn
- 2003-11-21 WO PCT/SE2003/001805 patent/WO2004048378A1/en active IP Right Grant
- 2003-11-21 EP EP07102257A patent/EP1813616B1/en not_active Expired - Lifetime
- 2003-11-21 CN CNB2003801066699A patent/CN100347173C/zh not_active Expired - Fee Related
- 2003-11-21 CA CA002506524A patent/CA2506524A1/en not_active Abandoned
- 2003-11-21 AU AU2003279687A patent/AU2003279687A1/en not_active Abandoned
- 2003-11-21 US US10/717,519 patent/US7081456B2/en not_active Expired - Lifetime
-
2005
- 2005-06-20 NO NO20053018A patent/NO20053018L/no not_active Application Discontinuation
-
2006
- 2006-05-30 US US11/442,548 patent/US7291612B2/en not_active Expired - Lifetime
- 2006-06-07 HK HK06106518A patent/HK1086562A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1562944A1 (en) | 2005-08-17 |
| US7081456B2 (en) | 2006-07-25 |
| CN100347173C (zh) | 2007-11-07 |
| CA2506524A1 (en) | 2004-06-10 |
| DE60311861T2 (de) | 2007-11-22 |
| ATE353898T1 (de) | 2007-03-15 |
| US20040116461A1 (en) | 2004-06-17 |
| DE60311861D1 (de) | 2007-03-29 |
| NO20053018D0 (no) | 2005-06-20 |
| ES2282693T3 (es) | 2007-10-16 |
| EP1562944B1 (en) | 2007-02-14 |
| NZ540081A (en) | 2008-03-28 |
| EP1813616A3 (en) | 2007-08-08 |
| HK1086562A1 (en) | 2006-09-22 |
| CN1729191A (zh) | 2006-02-01 |
| US20060217411A1 (en) | 2006-09-28 |
| WO2004048378A1 (en) | 2004-06-10 |
| US7291612B2 (en) | 2007-11-06 |
| RU2005119639A (ru) | 2006-01-20 |
| EP1813616A2 (en) | 2007-08-01 |
| JP2006509047A (ja) | 2006-03-16 |
| EP1813616B1 (en) | 2013-03-27 |
| US20050203118A9 (en) | 2005-09-15 |
| AU2003279687A1 (en) | 2004-06-18 |
| RU2328496C2 (ru) | 2008-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20053018L (no) | Pyrazoloquinoliner med immunmodulerende aktivitet. | |
| IL163629A0 (en) | Glutaminyl derivatives and pharmaceutical compositions containing the same | |
| WO2005092895A3 (en) | Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists | |
| WO2012080284A3 (en) | Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof | |
| DE50306845D1 (de) | Disubstituierte thiazolylcarboxanilide und ihre verwendung als mikrobizide | |
| MXPA06011194A (es) | Tiadiazolidinonas como inhibidores de gsk-3. | |
| DE60333371D1 (de) | 3-(sulfonamidoethyl)-indol-derivate zur verwendung als glucocorticoid-mimetika bei der behandlung von entzündlichen, allergischen und proliferativen erkrankungen | |
| HUP0303164A2 (hu) | Kinazolinok mint MMP-13 gátlók, eljárás az előállításukra, intermedierjeik és a vegyületeket tartalmazó gyógyszerkészítmények | |
| ATE384061T1 (de) | Imidazo- und thiazolopyridine als jak3-kinase- inhibitoren | |
| NO20072605L (no) | Nytt antranilinsyrederivat eller et salt derav | |
| EA200801134A1 (ru) | Замещенные бициклические пиримидоновые производные | |
| DK1725536T3 (da) | Imidazolin-derivater med CB1-antagonistisk aktivitet | |
| WO2004089366A8 (en) | Bicyclic compounds as nr2b receptor antagonists | |
| DK1765816T3 (da) | Substituerede 1-propinylpiperaziner med affinitet for MGluR5-receptoren til behandling af smertetilstande | |
| WO2009025839A3 (en) | Phosphodiesterase 10 inhibitors | |
| NO20035684L (no) | Immunomodulerende forbindelser | |
| PE20061080A1 (es) | Compuestos derivados de piridotienopirimidina como inhibidores de fosfodiesterasa 4 | |
| WO2003087062A3 (en) | 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation | |
| ATE425164T1 (de) | Tetrazyklische immunmodulierende verbindungen | |
| RU2015151042A (ru) | N-(2-фтор-2-фенэтил)карбоксамиды в качестве нематицидов и эндопаразитицидов | |
| DE602004029383D1 (de) | Isten und antagonisten | |
| NO20080285L (no) | Alfa-(aryl- eller heteroarylmetyl)-beta-piperidinopropionsyreforbindelser som ORL-1-reseptorantagonist | |
| NO20053562L (no) | Nye aminobenzofenonforbindelser | |
| WO2005025492A3 (en) | Novel compositions, pharmaceutical compositions, and methods for the treatment and prevention of heart disease | |
| NO20076676L (no) | Nye 8-sulfonyl-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |